USP4 and colorectal neoplasm: Moreover, genetic deletion of USP4 or treatment with USP4 inhibitor, Vialinin A,  inhibits colorectal tumor growth, implicating the potential clinical applications of USP4 inhibitors for future cancer  therapy.